Chemical Component Summary | |
---|---|
Name | DECAMETHONIUM ION |
Identifiers | trimethyl-(10-trimethylazaniumyldecyl)azanium |
Formula | C16 H38 N2 |
Molecular Weight | 258.486 |
Type | NON-POLYMER |
Isomeric SMILES | C[N+](C)(C)CCCCCCCCCC[N+](C)(C)C |
InChI | InChI=1S/C16H38N2/c1-17(2,3)15-13-11-9-7-8-10-12-14-16-18(4,5)6/h7-16H2,1-6H3/q+2 |
InChIKey | MTCUAOILFDZKCO-UHFFFAOYSA-N |
Chemical Details | |
---|---|
Formal Charge | 2 |
Atom Count | 56 |
Chiral Atom Count | 0 |
Bond Count | 55 |
Aromatic Bond Count | 0 |
Drug Info: DrugBank
DrugBank ID | DB01245 |
---|---|
Name | Decamethonium |
Groups | approved |
Description | Decamethonium is used in anesthesia to cause paralysis. It is a short acting depolarizing muscle relaxant. It is similar to acetylcholine and acts as a partial agonist of the nicotinic acetylcholine receptor. |
Synonyms |
|
Indication | For use as a skeletal muscle relaxant |
Categories |
|
CAS number | 156-74-1 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Neuronal acetylcholine receptor subunit alpha-2 | MGPSCPVFLSFTKLSLWWLLLTPAGGEEAKRPPPRAPGDPLSSPSPTALP... | unknown | partial agonist |
Neuronal acetylcholine receptor subunit alpha-4 | MELGGPGAPRLLPPLLLLLGTGLLRASSHVETRAHAEERLLKKLFSGYNK... | unknown | |
Neuronal acetylcholine receptor subunit beta-2 | MARRCGPVALLLGFGLLRLCSGVWGTDTEERLVEHLLDPSRYNKLIRPAT... | unknown | |
Acetylcholinesterase | MRPPQCLLHTPSLASPLLLLLLWLLGGGVGAEGREDAELLVTVRGGRLRG... | unknown | inhibitor |
Cholinesterase | MHSKVTIICIRFLFWFLLLCMLIGKSHTEDDIIIATKNGKVRGMNLTVFG... | unknown | inhibitor |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL1190 |
PubChem | 2968 |
ChEMBL | CHEMBL1190 |
ChEBI | CHEBI:41934 |